JENNIFER PIKER: Open Payments
NPI 1285895060 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,977 in 102 payments from 16 companies in 2025. Trend: 2023 $2,562 · 2024 $2,104 · 2025 $1,977
Food & beverage: $1,868Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $404 |
| Janssen Biotech, Inc. | 19 | $398 |
| Lilly USA, LLC | 12 | $241 |
| Amgen Inc. | 9 | $169 |
| Organon LLC | 8 | $93 |
| Almirall LLC | 4 | $92 |
| Arcutis Biotherapeutics, Inc. | 5 | $91 |
| Incyte Corporation | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| GENZYME CORPORATION | 2 | $63 |
Products named: TREMFYA, SKYRIZI, TALTZ, Otezla, Zoryve, OPZELURA, COSENTYX, DUPIXENT.
Industry payments across LA — which companies pay providers there.
